Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors

This study has been terminated.
(Sponsor decision - subjects rolled over to protocol 20101116)
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT00819169
First received: January 6, 2009
Last updated: September 16, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2011
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 13, 2015